Guardian Partners Inc. Novartis Ag Transaction History
Guardian Partners Inc.
- $1.11 Trillion
- Q2 2025
A detailed history of Guardian Partners Inc. transactions in Novartis Ag stock. As of the latest transaction made, Guardian Partners Inc. holds 2,140 shares of NVS stock, worth $264,910. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,140
Previous 2,140
-0.0%
Holding current value
$264,910
Previous $236 Million
11.63%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,582Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.32 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.29 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.12 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$936 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$882 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $266B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...